Want to see GB:SYNT full AI Analyst Report?
SYNT Stock Chart & Stats
84.60 p
-3.40 p(-4.02%)
At close: 4:00 PM EDT
84.60 p
-3.40 p(-4.02%)
Day’s Range― - ―
52-Week Range16.70 p - 123.95 p
Previous CloseN/A
Volume661.64K
Average Volume (3M)1.10M
Market Cap
£164.93M
Enterprise Value856.18 p
Total Cash (Recent Filing)£182.60M
Total Debt (Recent Filing)£893.90M
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding163,997,630
10 Day Avg. Volume933,327
30 Day Avg. Volume1,097,050
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.11
Price to Sales (P/S)0.06
P/FCF Ratio2.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£118.75Price Target Upside40.37% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.08
Revenue Forecast (FY)£1.88B
Bulls Say, Bears Say
Bulls Say
Operating Growth And Margin ExpansionBroad-based volume growth and higher EBITDA margins indicate improving pricing, mix and operating execution. If sustained, this can strengthen earnings quality and provide greater resilience across Synthomer’s industrial end markets.
Transformation And Specialty-Market PositionTransformation savings and growth in health and protection applications support a more efficient, differentiated portfolio. Specialty formulations and market positions can improve mix and reduce reliance on lower-value commodity demand over time.
Deleveraging And Cash-Flow ImprovementPositive underlying cash generation, planned disposals and refinancing through 2029 could materially improve financial flexibility. Lower leverage would reduce balance-sheet risk and support continued investment in selected specialty businesses.
Bears Say
Persistent Losses And Revenue DeclineSustained losses and a declining recent revenue base indicate that the recovery is not yet firmly established. Continued weak profitability could erode equity, limit reinvestment capacity and make performance more sensitive to end-market cycles.
Elevated Leverage And Interest BurdenHigh leverage and rising financing costs absorb cash that could otherwise fund growth or resilience measures. The deleveraging plan is constructive, but execution remains important because covenant and liquidity constraints can restrict strategic flexibility.
Manufacturing Reliability And Demand RisksOperational disruptions directly reduce margins and can weaken customer confidence if service levels deteriorate. Concurrent softness in decorative coatings, consumer materials and Performance Materials raises the risk that recovery depends on selective rather than broad demand improvement.
SYNT FAQ
What was Synthomer PLC’s price range in the past 12 months?
Synthomer PLC lowest share price was 16.70 p and its highest was 123.95 p in the past 12 months.
What is Synthomer PLC’s market cap?
Synthomer PLC’s market cap is £164.93M.
When is Synthomer PLC’s upcoming earnings report date?
Synthomer PLC’s upcoming earnings report date is Mar 04, 2027 which is in 194 days.
How were Synthomer PLC’s earnings last quarter?
Synthomer PLC released its earnings results on Aug 04, 2026. The company reported 0.215 p earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Synthomer PLC overvalued?
According to Wall Street analysts Synthomer PLC’s price is currently Undervalued.
Does Synthomer PLC pay dividends?
Synthomer PLC pays a Notavailable dividend of 156.896 p which represents an annual dividend yield of N/A. See more information on Synthomer PLC dividends here
What is Synthomer PLC’s EPS estimate?
Synthomer PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synthomer PLC have?
Synthomer PLC has 163,997,630 shares outstanding.
What happened to Synthomer PLC’s price movement after its last earnings report?
Synthomer PLC reported an EPS of 0.215 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.236%.
Which hedge fund is a major shareholder of Synthomer PLC?
Currently, no hedge funds are holding shares in GB:SYNT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Synthomer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£118.75 (40.37% Upside)
£118.75 (40.37% Upside)
Blogger Sentiment
Neutral
GB:SYNT Sentiment 100%
Sector Average 62%
Sector Average 62%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.47%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.98%
Trailing 12-Months
Company Description
Synthomer PLC
Synthomer plc functions as a leading producer of specialty chemicals, with its operations organized into four primary divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company develops and supplies an extensive array of chemical products serving various industries. Its offerings include a wide selection of adhesives, such as pressure-sensitive variants, acrylic polymers, dispersions, saturants, and release coatings. For the construction sector, Synthomer provides critical materials like water-based carboxylated styrene butadiene rubber, redispersible powders, and specialized flooring adhesives. In the textile industry, it manufactures impregnation binders, styrene butadiene copolymers, and other polymer binders. Synthomer's product range also features binders specifically designed for carpets, alongside synthetic binders, additives, and plastic pigments essential for diverse paper coating applications, including graphic, packaging, and specialty papers. The company formulates various binders, dispersions, and both water-based and solvent-borne resins tailored for a broad spectrum of coating requirements. Its advanced materials extend to components for foamed bedding and footwear, elastomeric modifiers used in thermoplastics, and reinforcement resins vital for rubber compounds, notably latex for tire cords. Furthermore, Synthomer supplies compounds and aqueous curing pastes for applications such as carpets, in addition to acrylic monomers crafted to enhance the performance characteristics of polymer formulations, and antioxidant products. A key area of its specialization involves latices for different types of gloves, encompassing those used in medical examinations, clean rooms, food handling, and industrial settings, prominently including high-performance nitrile latex. The company also offers a suite of industrial chemicals suchides, polyvinyl alcohol, polyvinyl acetates, thermosetting resins, and other inorganic materials, alongside coalescing agents that improve the properties of coatings. Established in 1863, Synthomer plc maintains its headquarters in London, United Kingdom. The company underwent a name change in 2012, having formerly operated under the name Yule Catto & Co. plc.
SYNT Stock 12 Month Forecast
Average Price Target
118.75 p
▲(40.37% Upside)







